How much does Pharmapac (U.K.) Limited make?

Pharmapac (U.K.) Limited reported revenue of £10.8m and £94.7k profit in the year to 30 Jun 2025, according to its accounts filed at Companies House.

How many employees does Pharmapac (U.K.) Limited have?

Pharmapac (U.K.) Limited reported an average of 142 employees in the year to 30 Jun 2025.

Is Pharmapac (U.K.) Limited profitable?

Yes — Pharmapac (U.K.) Limited reported a profit of £94.7k in the year to 30 Jun 2025.

Company No. 03201556 · Incorporated 21 May 1996

Pharmapac (U.K.) Limited

Registered name: PHARMAPAC (U.K.) LIMITED

Part of Pharmapac Holdings Limited group

Pharmapac (U.K.) Limited made £10.8m revenue and £94.7k profit in the year to 30 Jun 2025.

Pharmapac (U.K.) Limited’s revenue fell 11% to £10.8m in the year to 30 Jun 2025, with £94.7k profit and 142 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Bidston, Wirral; we hold 4 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 21100Manufacture of basic pharmaceutical products

Status: Active
Location: Bidston, Wirral, North West
Age: 30 yrs · since 1996
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 30 Jun 2025

Key figures

Revenue

£10.8m

Growth ▼11.2%

Profit

£94.7k

Growth ▼56.8%

Profit margin

0.9%

Gross 30.2%

Employees

142

Change ▼5.3%

Profit / employee

£667

Revenue/employee £76k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Jun 2022	30 Jun 2023	30 Jun 2024	30 Jun 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£19.7m	£16.5m	£12.2m	£10.8m
Cost of sales	£13.6m	£10.7m	£8.4m	£7.5m
Gross profit	£6.2m	£5.7m	£3.7m	£3.3m
Operating profit	£3.4m	£3m	£546k	£42.9k
Profit before tax	£3.3m	£2.9m	£541k	£16.3k
Profit after tax	£2.8m	£2.5m	£219k	£94.7k
Profit (best available)	£2.8m	£2.5m	£219k	£94.7k
Staff costs	£4.2m	£3.7m	£5.1m	£5m
Employees (average)	137	133	150	142
Ratios
Profit margin	14.2%	15.4%	1.8%	0.9%
Gross margin	31.2%	34.8%	30.6%	30.2%
Revenue per employee	£144k	£124k	£81k	£76k
Profit per employee	£20.5k	£19.1k	£1.5k	£667
Growth (year on year)
Revenue growth	—	▼16.5%	▼26.2%	▼11.2%
Profit growth	—	▼9.6%	▼91.4%	▼56.8%
Headcount growth	—	▼2.9%	▲12.8%	▼5.3%
Balance sheet — indirect signals, not revenue
Cash at bank	£3.2m	£3.9m	£447k	£185k
Net assets	£8.4m	£7.9m	£8.1m	£8.2m
Fixed assets	£5m	£5.1m	£5.8m	£5m
Current assets	£15.9m	£9.5m	£7.1m	£9.4m
Debtors	£3.3m	£3m	£3.5m	£1.9m
Deferred income	£6.5m	£717k	£281k	£324k
Source	FullAccounts · bulk data Mar 2024	FullAccounts · bulk data Mar 2024	FullAccounts · bulk data Feb 2025	FullAccounts · bulk data Jun 2026

Derived from the latest filing

How the business works

Profit margin: 0.9%; Profit ÷ revenue.
Gross margin: 30.2%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £76k; Revenue ÷ average employees.
Profit per employee: £667; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 46.3%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 3%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 18%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲1%; Now £8.2m
Cash at bank: ▼59%; Now £185k
Headcount: ▼5%; Now 142
Deferred income: ▲15%; Now £324k
Fixed assets: ▼14%; Now £5m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Pharmapac Holdings Limitedultimate parent75–100%
Pharmapac (U.K.) Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (4)

Vector Consumer LimitedRev. £10.6m · Profit £33.1k
Bapell Group LimitedFigures not disclosed
Pharmapac Ventures LimitedFigures not disclosed
Vector Consumer Europe LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Jun 2025 (profit £94.7k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.